Oligopeptide

Affimed brings new antibody to the clinic

Wednesday 15 September 2010

Interviewee/Contributer: Rolf Günther

Organisation: Affimed Therapeutics AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content